Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Non-Current Debt of $379.1 million for Q1 2026, up 14.94% year-over-year from $329.8 million in Q1 2025, and down 6.26% quarter-over-quarter from $404.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Debt (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Non-Current Debt for 7 consecutive years, with $379.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt rose 14.94% year-over-year to $379.1 million; the TTM figure through Mar 2026 stood at $379.1 million (up 14.94% YoY), while the FY2025 annual figure was $404.4 million, up 219.1% from the prior year.
- Non-Current Debt declined to $379.1 million in Q1 2026 per STVN's latest filing, from $404.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $430.3 million in Q3 2025 and bottomed at -$339.5 million in Q4 2024.
- Historically, Non-Current Debt has averaged $184.7 million across 5 years, with a median of $221.4 million in 2022.
- Annual changes were most pronounced in 2023 — Non-Current Debt sank 81.64% — and 2025, when it jumped 219.1%.
- Stevanato Group S.p.A's Non-Current Debt stood at -$151.4 million in 2022, then tumbled by 81.64% to -$275.0 million in 2023, then decreased by 23.45% to -$339.5 million in 2024, then surged by 219.1% to $404.4 million in 2025, then declined by 6.26% to $379.1 million in 2026.
- Business Quant data shows STVN's Non-Current Debt at $379.1 million in Q1 2026, $404.4 million in Q4 2025, and $430.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 370.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 370.86 Mn |
| Mar 31, 2026 | 379.05 Mn |
| Dec 31, 2025 | 404.35 Mn |
| Sep 30, 2025 | 430.31 Mn |
| Jun 30, 2025 | 387.85 Mn |
| Mar 31, 2025 | 329.79 Mn |
| Dec 31, 2024 | -339.49 Mn |
| Sep 30, 2024 | 317.79 Mn |
| Jun 30, 2024 | 271.78 Mn |
| Mar 31, 2024 | 304.76 Mn |
| Dec 31, 2023 | -275.01 Mn |
| Sep 30, 2023 | 213.70 Mn |
| Jun 30, 2023 | 131.62 Mn |
| Mar 31, 2023 | 153.78 Mn |
| Dec 31, 2022 | -151.40 Mn |
| Sep 30, 2022 | 172.23 Mn |
| Jun 30, 2022 | 187.21 Mn |
| Mar 31, 2022 | 221.36 Mn |
| Dec 31, 2021 | -231.43 Mn |
| Sep 30, 2021 | 279.62 Mn |